grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

December 17, 2013

Omnicell Appoints Kimberly-Clark's Joanne Bauer to Board of Directors

Download PDF

MOUNTAIN VIEW, Calif., Dec. 17, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL) today announced the appointment of Joanne Bauer, president of global Health Care at Kimberly-Clark, to its board of directors and as a member of the Corporate Governance Committee of the board. Her role will be effective January 1, 2014. Ms. Bauer brings diverse experiences that include strategic planning, international business management, and mergers and acquisitions to the board to provide insight on leadership and product matters.


"A recognized and respected leader in the health care sector, Joanne will bring valuable strategic counsel to our board. Her depth of knowledge and leadership gained by managing the large-scale finances and logistics of Kimberly-Clark Health Care brands will be a strong addition to our advisory infrastructure," said Randy Lipps, Omnicell president, chairman and CEO. "Joanne's extensive experience and acumen with lean management principles, mergers and acquisitions, and in navigating the health care industry's regulatory process will also complement the experience of our current directors."

Ms. Bauer leads multispecialty businesses across the pain management, respiratory, digestive health and infection prevention sectors. She joined Kimberly-Clark in 1981 and has held various marketing and management positions within its adult care and health care businesses. She was elected president of Kimberly-Clark's global health care business in 2006, where she is responsible for a variety of surgical and infection prevention products and medical devices.

Ms. Bauer served on the board of directors for Medivance, Inc., a startup medical device company that was sold to BARD in October of 2011.  She currently serves on the executive committee of the board of directors for MedShare, an Atlanta based non-profit organization, and the board of directors of AdvaMed—the Advanced Medical Technology Association.

"As our hospitals and health systems rely more on technology to improve efficiency and patient care, Omnicell offers the right approach and technologies to help these organizations achieve their goals," said Ms. Bauer. "I am honored to have the opportunity to contribute my insights and experiences to help guide such an important health care innovator as Omnicell."

About Omnicell

For more than 20 years the mission of Omnicell (NASDAQ: OMCL) has been to create new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire health care continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.

Since 1992, more than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions that can reduce costly hospital readmissions and enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.

SOURCE Omnicell, Inc.

News Provided by Acquire Media